AVROBIO Inc.

NASDAQ: AVRO · Real-Time Price · USD
1.40
-0.02 (-1.41%)
At close: Jun 20, 2024, 10:00 PM

AVROBIO Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 7.2M 7.2M 3.6M 3.6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a 2.68M 3.6M 4.86M 5.2M 4.67M 3.75M 690K 354K n/a n/a n/a n/a n/a
Gross Profit
n/a n/a 3.6M 3.6M 920K n/a -4.86M -5.2M -4.67M -3.75M -690K -354K n/a n/a n/a n/a n/a
Operating Income
-68.7M -58.02M -49.8M -53.1M 27.83M 10.23M -5.4M -5.46M -101.24M -105.43M -108.14M -117.77M -121.38M -118.84M -118.94M -123.04M -120.52M
Interest Income
6.71M 4.26M 3.93M 3.38M 2.67M 2.92M 1.66M 359.69K 359.25K 111.25K 111K 2K 11K 21K 34K 44K 97K
Pretax Income
-67.08M -57.98M -45.2M -49.06M 30.68M 12.53M -4.09M -5.48M -101.01M -105.89M -109.08M -118.73M -122.06M -119.13M -119.03M -123.2M -120.64M
Net Income
-67.08M -57.98M -45.95M -49.81M 30.31M 13M 54.35M 53.09M -42.73M -48.85M -109.65M -119.42M -122.47M -119.13M -119.03M -123.2M -120.64M
Selling & General & Admin
14.65M 16.65M 19.89M 20.83M 23.34M 23.97M 25.85M 26.65M 30.97M 33.25M 35.09M 37.6M 37.53M 35.73M 35.24M 33.87M 33.03M
Research & Development
53.72M 41.36M 24.07M 24.58M 31.05M 47.7M 61.45M 62.54M 70.27M 72.19M 73.05M 80.17M 83.84M 83.11M 83.7M 89.17M 87.49M
Other Expenses
n/a n/a -76K -127K -93K 170K 399K 355K 396K 88K -400K -300K -326K -306K -108K -187K -199K
Operating Expenses
68.7M 58.02M 43.96M 45.41M 54.06M 71.67M 87.3M 89.19M 101.24M 105.43M 108.14M 117.77M 121.38M 118.84M 118.94M 123.04M 120.52M
Interest Expense
-127K -107K 1.95M 3.38M 2.17M 2.42M 2.34M 1.04M 832K 584K 396K 285K n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -105K -105K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
-7.62M n/a -15.86M 5.24M 54.06M 71.67M 87.3M 89.19M 101.24M 105.43M 108.14M 117.77M 121.38M 118.84M 118.94M 123.04M 120.52M
Income Tax Expense
n/a n/a -2.65M -2.65M 836K -3K -57.98M -58.11M -58.29M -57.03M 568K 693K 404K -21K -21K -31K -84K
Shares Outstanding (Basic)
17.16M 8.49M 14.73M 14.73M 44.79M 4.46M 44.53M 44.13M 44.04M 43.79M 43.77M 43.7M 43.7M 43.65M 43.62M 42.51M 41.62M
Shares Outstanding (Diluted)
17.16M 8.49M 14.73M 14.73M 44.79M 4.46M 44.53M 44.28M 44.04M 43.79M 43.77M 43.7M 43.7M 43.65M 43.62M 42.51M 41.62M
EPS (Basic)
-7.61 -6.83 -1.03 -0.31 0.70 0.30 1.24 1.20 -0.98 -1.12 -2.51 -2.74 -2.83 -2.79 -2.87 -3.13 -3.19
EPS (Diluted)
-7.61 -6.83 -1.03 -0.31 0.69 0.29 1.23 1.19 -0.98 -1.12 -2.51 -2.74 -2.83 -2.79 -2.87 -3.13 -3.19
EBITDA
-68.7M -58.02M -44.3M -43.91M -51.97M -69.57M -85.2M -88.59M -100.53M -104.33M -107.03M -116.65M -120.3M -117.88M -117.98M -122.14M -119.62M
EBIT
n/a n/a -36.45M -56.62M 39.66M 14.95M -1.75M -4.44M -100.18M -105.68M -109.28M -119.04M -122.65M -119.33M -90.88M -94.98M -92.46M
Depreciation & Amortization
n/a n/a 3.81M 7.5M 4.02M 4.34M 4.64M 1.3M 1.37M 1.44M 1.54M 1.56M 1.51M 1.4M 1.27M 1.21M 1.22M